title: [Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells].
authors.forename: S
authors.initials: S
authors.lastname: Osanto
authors.forename: A
authors.initials: A
authors.lastname: Brand
authors.forename: J J
authors.initials: JJ
authors.lastname: van Rood
authors.forename: F J
authors.initials: FJ
authors.lastname: Cleton
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated; D009369:Neoplasms / Q000628:therapy*
chemical_list: D007376:Interleukin-2
vernacular_title: Immunotherapie van kanker met interleukine-2 en met interleukine-2 geactiveerde cellen.